Table II. Surgical models used for renal fibrosis study – drugs evaluated and their efficacy.

s.c.: Subcutaneous; i.p.: intraperitoneal; p.o.: per os; TGFβ: transforming growth factor-β; TWEAK: tumour necrosis factor-like weak inducer of apoptosis; Ang II: angiotensin II; AT1: angiotensin II type-1; UUO: unilateral ureteral obstruction; coll-GFP: collagen type I-α 1 transcript.